Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Sandler

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junctionA B Sandler, H L Kindler, L H Einhorn, et al.
The International Journal of Biological Markers|October 1, 1994
Correlation between lipid-associated sialic acid and tumor burden in melanomaA C Buzaid, A B Sandler, C L Hayden, et al.
American Journal of Clinical Oncology|October 1, 1994
Neuron-specific enolase as a tumor marker in metastatic melanomaA C Buzaid, A B Sandler, C L Hayden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Role of computed tomography in the staging of primary melanomaA C Buzaid, A B Sandler, S Mani, et al.
British Journal of Cancer|August 15, 2013
Baseline tumour measurements predict survival in advanced non-small cell lung cancerD E Gerber, S E Dahlberg, A B Sandler, et al.
Cancer|December 18, 2001
Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma C J Sweeney, J Zhu, A B Sandler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancerJ-C Soria, A Mauguen, M Reck, et al.
Clinical Lung Cancer|January 17, 2004
Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trialM A Socinski, A B Sandler, L L Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancerM A Socinski, A B Sandler, L L Miller, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumabH A Wakelee, S E Dahlberg, J R Brahmer, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junctionA B Sandler, H L Kindler, L H Einhorn, et al.
The International Journal of Biological Markers|October 1, 1994
Correlation between lipid-associated sialic acid and tumor burden in melanomaA C Buzaid, A B Sandler, C L Hayden, et al.
American Journal of Clinical Oncology|October 1, 1994
Neuron-specific enolase as a tumor marker in metastatic melanomaA C Buzaid, A B Sandler, C L Hayden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Role of computed tomography in the staging of primary melanomaA C Buzaid, A B Sandler, S Mani, et al.
British Journal of Cancer|August 15, 2013
Baseline tumour measurements predict survival in advanced non-small cell lung cancerD E Gerber, S E Dahlberg, A B Sandler, et al.
Cancer|December 18, 2001
Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma C J Sweeney, J Zhu, A B Sandler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancerJ-C Soria, A Mauguen, M Reck, et al.
Clinical Lung Cancer|January 17, 2004
Irinotecan (CPT-11) in triplet combinations in patients with advanced non small-cell lung cancer: a review and report of a phase I/II trialM A Socinski, A B Sandler, L L Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancerM A Socinski, A B Sandler, L L Miller, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumabH A Wakelee, S E Dahlberg, J R Brahmer, et al.
Pageof 4